The Net Margin of CytomX Therapeutics Inc (CTMX) is 23.08%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | 23.08% |
| 2023-12-31 | -0.56% |
| 2022-12-31 | -186.65% |
| 2021-12-31 | -310.72% |
| 2020-12-31 | -32.77% |
| 2019-12-31 | -177.74% |
| 2018-12-31 | -142.18% |
| 2017-12-31 | -60.20% |
| 2016-12-31 | -392.67% |
| 2015-12-31 | -459.74% |